← Back to Patent Explorer
US4703003A Expired / Lapsed US ⏱️ 0.0 years remaining

Monoclonal antibody with a high affinity for digoxin

Assignee: Roche Diagnostics GmbH
•
Filing: 1984-08-13
•
Granted: 1987-10-27
•
Expires: 2004-08-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A hybridoma which produces monoclonal antibodies having a high affinity and selectivity for digoxin is produced by immunizing mice with digoxin, fusing the spleen cells from the treated mice with mice myeloma cells, separating hybrids from non-fused cells, selecting the hybrids which produce monoclonal antibodies directed against digoxin and isolating the hybrids.

Inventors

  • 👤 Carl-Julius Struck

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 14:00
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/44; A; A61; A61P; A61P9/00; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/948

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 31 words
A hybridoma which produces monoclonal antibodies having a high affinity and selectivity for digoxin, a cross-reactivity of less than 1.3% with digitoxin and a cross-reactivity of less than 0.007% with spironolactone.
Claim 2
Dependent Claim 31 words
A hybridoma which produces monoclonal antibodies having a high affinity and selectivity for digoxin, a cross-reactivity of less than 1.3% with digitoxin and a cross-reactivity of less than 0.007% with spironolactone.
Claim 3
Dependent Claim 25 words
A hybridoma of claim 1 produced by immunizing mice with digoxin and carrying out selection of the hybrid cells with digoxin, digitalis glycosides and spironolactone.
Claim 4
Dependent Claim 15 words
A hybridoma of claim 2 which is produced by using digitoxin as the digitalis glycoside.
Claim 5
Dependent Claim 28 words
A monoclonal antibody having a high affinity and specificity for digoxin, a cross-reactivity of less than 1.3% with digitoxin and a cross-reactivity of less than 0.007% with spironalactone.
Claim 6
Dependent Claim 28 words
A monoclonal antibody having a high affinity and specificity for digoxin, a cross-reactivity of less than 1.3% with digitoxin and a cross-reactivity of less than 0.007% with spironalactone.
Claim 7
Dependent Claim 33 words
A monoclonal antibody of claim 4 which is prepared by immunizing mice with digoxin, carrying out the selection of the hybrid cells with digoxin, digitalis glycosides and spironolactone, and isolating the monoclonal antibody.
Claim 8
Dependent Claim 16 words
A monoclonal antibody of claim 5 which is produced by using digitoxin as the digitalis glycoside.
Claim 9
Dependent Claim 58 words
The method of producing a hybridoma of claim 1, which comprises (a) immunizing mice with digoxin, (b) fusing the spleen cells from the treated mice with mouse myeloma cells, (c) separating hybrids from non-fused cells, (d) selecting the hybrids which produce monoclonal antibodies directed against digoxin by using digoxin, digitalis glycosides and sprionolactone, and (e) isolating the hybrids.
Claim 10
Dependent Claim 13 words
The method of claim 7 where digitoxin is used as the digitalis glycoside.
Claim 11
Dependent Claim 70 words
The method of producing a monoclonal antibody of claim 4, which comprises (a) immunizing mice with digoxin, (b) fusing spleen cells from the treated mice with mouse myeloma cells, (c) separating hybrids from non-fused cells, (d) selecting the hybrids which produce monoclonal antibodies directed against digoxin by using digoxin digitalis glycosides and spironolactone, and (e) isolating the monoclonal antibodies after the growth of the cells in vivo or in vitro.
Claim 12
Dependent Claim 13 words
The method of claim 9, where digitoxin is used as the digitalis glycoside.

References Cited (Backward Citations)

US4477576A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-10-26 1991-04-27 1991-10-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-10-26 1995-04-27 1995-10-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-10-26 1999-04-27 1999-10-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag